Following are two updates on regulations relating to standards in cosmetic/aesthetic medicine and surgery in the UK and Europe. Dr. Jean Devroye has been supported by the ISHRS in his efforts to voice opinion on regulations relating to the practice of hair transplant surgery. —NF
There have been two important documents relevant to Hair Transplant Surgery published in 2013 in the United Kingdom (UK). The British Association of Hair Restoration Surgery (BAHRS) intends to imminently publish Professional Standards for Hair Transplant Surgery taking into account the contents of the first and the recommendations of the second.
The first document is the Royal College of Surgeons of England’s Professional Standards for Cosmetic Practice1 written by the Cosmetic Surgical Practice Working Party in January 2013 in response to the 2010 National Confidential Enquiry into Patient Outcome and Death report On the Face of It.2 It calls for all doctors in the field of cosmetic practice to abide by a number of principles.
Virtually all cosmetic practice in the UK occurs in the Independent Health Sector outside the remit of the National Health Service (NHS). Arguably, this leads to less close regulation of the sector. Doctors from a range of specialties undertake Cosmetic Surgery with varying degrees of training and experience. Non-surgical procedures such as laser treatment, injectables (e.g., Botox®), and fillers may be administered by those with no healthcare qualifications whatsoever.
In this document it is recommended that only licensed doctors, registered dentists, and registered nurses should provide any cosmetic treatments (including laser treatments and injectable cosmetic treatments). Invasive procedures (including Hair Transplant Surgery according to the definition of “invasive procedures” therein) would only be carried out by licensed doctors on the General Medical Council’s (GMC’s) specialist register for surgical specialties or those who were practicing Cosmetic Surgery in the Independent Health Care Sector prior to 1st April 2002.
In drawing together the standards for all cosmetic practitioners, the working group highlights the following common standards. Practitioners must
make their professional qualifications clear to patients,
inform patients about the full financial implications of the procedure that they are requesting before signing a consent form,
ensure marketing is honest and responsible and adheres to standards laid out by the relevant professional regulator,
have in place procedures for handling patient complaints,
have in place indemnity insurance that is adequate for the procedures that are undertaken, and
have completed life skills training in compliance with the UK Resuscitation Council guidelines and ensure patients have access to help at all times.
It is recommended that practitioners should adhere to the process of patient care outlined in this document, which highlights the importance of preparing the patient before the procedure, ensuring the patient has a full understanding of the risks involved in the procedure, consideration of the need for a psychological assessment, and the pre- and post-operative requirements of the procedures.
The second document, Review of the Regulations of Cosmetic Interventions, was published by the Department of Health in the UK in April 2013. It was written by a Review Committee under the leadership of Professor Sir Bruce Keogh, NHS Medical Director, and is commonly referred to as the Keogh Report on Cosmetic Surgery.
This group was asked to review regulation in the cosmetic interventions sector in the UK following the Poly Implant Prothèse (PIP) silicone breast implant scandal that exposed woeful lapses in product quality, after care, and recordkeeping. It also drew attention to widespread use of misleading advertising, inappropriate marketing, and unsafe practices across the sector. Cosmetic interventions are a booming business in the UK, worth £2.3 billion in 2010, and estimated to rise to £3.6 billion by 2015.
There were 40 separate recommendations that covered three key areas in which changes are needed:
High-quality care with safe products, skilled practitioners, and responsible providers.
An informed and empowered public to ensure people get accurate advice and that the vulnerable are protected.
Accessible redress and resolution in case things go wrong.
With respect to high-quality care, the following recommendations were made:
The scope of the EU Medical Devices Directive should be extended to include all cosmetic implants including dermal fillers. UK legislation should be introduced to enact the changes sooner. Legislation should be introduced to classify fillers as a prescription-only medical device.
The Royal College of Surgeons (RCS) should establish an Interspecialty Committee on Cosmetic Surgery, made up of representatives of all the relevant specialty and professional associations. The purpose of this group would be to set standards for cosmetic surgery practice and training, and make arrangements for formal certification of all surgeons regarded as competent to undertake cosmetic procedures, taking account of training and experience.
Those performing cosmetic interventions must be registered.
The Health Education England’s (HEE’s) mandate should include the development of appropriate accredited qualifications for providers of non-surgical interventions and it should determine accreditation requirements for the various professional groups. This work should be completed in 2013.
Surgical providers should provide both the person undergoing a procedure and their GP with proper records.
A breast implant registry should be established within the next 12 months and extended to other cosmetic devices as soon as possible, to provide better monitoring of patient outcomes and device safety.
With respect to an informed and empowered public, the following recommendations were made:
The RCS Interspecialty Committee on Cosmetic Surgery should develop and describe a multi-stage consent process for operations. Consent must be taken by the surgeon performing the operation to ensure that the patient and practitioner have a shared understanding of the desired outcome and the limitations, implications, and risks of the procedure.
Evidence-based standardised patient information should be developed by the RCS Interspecialty Committee on Cosmetic Surgery, with input from patient organisations.
For non-surgical procedures, a record of consent must be held by the provider.
Existing advertising recommendations and restrictions should be updated and better enforced.
The use of financial inducements and time-limited deals to promote cosmetic interventions should be prohibited to avoid inappropriate influencing of vulnerable consumers.
With regards to accessible resolution and redress, the following recommendations were made:
The remit of the Parliamentary and Health Service Ombudsman (PHSO) should be extended to cover the whole private healthcare sector. This will de facto include cosmetic procedures of all kinds.
All individuals performing cosmetic procedures must possess adequate professional indemnity cover that is commensurate with the type of operations being performed.
The Review Committee supports the future development of insurance products, such as risk pool arrangements, to cover product failure and certain complications of surgery.
The Royal College of Surgeons of England’s Professional Standards for Cosmetic Practice provides guidance to clinicians for ethical practice. The Department of Health’s Review of the Regulation of Cosmetic Interventions provides guidance to the government and forms a framework for new legislation. Neither is legally binding, but Hair Transplant Surgeons in the UK need to be aware that principles laid out in these two documents might become part of government legislation in the future. The European Union’s European Standard for Aesthetic Surgery Services is undergoing final draft review and is also likely to have an impact on Hair Transplant Surgery provision in the UK when it is published
- Copyright © 2013 by The International Society of Hair Restoration Surgery